• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Brazil begins producing flu vaccine

Sally Furniss

Well-known member
Brazil begins producing flu vaccine

http://english.people.com.cn/200704/27/eng20070427_370284.html

Brazil started its own flu vaccine production on Thursday, aimed at achieving self-sufficiency in the sector.

The Brazilian authorities said the vaccine will be produced by the Butanta Institute, in Sao Paulo, with a production capacity of 40 million vaccines per year. The institute is now one of the five labs in the world to be licensed to produce the vaccine.

The project was carried out under a technology transfer agreement signed with French pharmaceutical company Sanofi-Aventis in 1999, when Brazil launched its national campaign to protect the elderly against seasonal influenza. Butanta's production capacity will be twice the amount necessary to fulfill the campaign.

The production of the vaccine will cost 78 million reals (38.6 million U.S. dollars), which is expected to help the Brazilian government save 100 million reals (49.5 million dollars) in treatment expenses per year.

The Health Ministry said the project will universalize public immunization in Brazil, which is currently available only to citizens over the age of 60.
 
Back
Top